In a long-standing department tradition, the newest Ph.D. students brought their early research to an audience of faculty and colleagues. Said Ph.D. program director Dr. Jamie Bernard: "It was an opportunity to effectively communicate science."
The Ghana native sent a cold email from a colder Scotland to Dr. James Luyendyk seeking to study PhmTox at MSU and it has proven to be an educational relationship for both of them
He has taken his MSU training to Worldwide Clinical Trials where he works with pharmaceutical companies to establish clinical trials for people afflicted with rare diseases. "The long-term goal is always to get the drug approved,” he said.
One of his Dr. Richard Neubig's goals when he came to MSU in 2013 was to create and build a Drug Discovery program, a relatively new direction in the world of drug research. Mission accomplished.